MYD88 and diffuse large B-cell lymphoma: In MYC+ tumors, a MYC R was the single driver alteration, and evolution patterns revealed RCAs associated with reported gene expression profiles in MYC+ DLBCL, mainly FOXP1, MYD88, CD79B, PIM1, and CARD11 (Figure 5).